drugset / Trial / NCT02920047

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects

NCT02920047

Phase 1 Completed 60 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the pharmacokinetics and safety when administrated Fimasartan/Amlodipine and when co-administrated Fimasartan and Amlodipine.

Timeline

Start
2016-10
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Fimasartan Small molecule

Indications